May 16, 2018 / 12:41 PM / 7 months ago

BRIEF-Hemispherx Biopharma Reports Q1 Operating Loss Per Share Of $0.70

May 16 (Reuters) - Hemispherx Biopharma Inc:

* HEMISPHERX BIOPHARMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 OPERATING LOSS PER SHARE $0.70 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below